Perpetually Adaptive Enterprise
At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
- Banking
- Capital Markets
- Consumer Packaged Goods and Distribution
- Communications, Media, and Information Services
- Education
- Energy, Resources, and Utilities
- Healthcare
- High Tech
- Insurance
- Life Sciences
- Manufacturing
- Public Services
- Retail
- Travel and Logistics
- Artificial Intelligence and Data & Analytics
- Cloud
- Cognitive Business Operations
- Consulting
- Cybersecurity
- Enterprise Solutions
- IoT and Digital Engineering
- Network Solutions and Services
- Sustainability Services
- TCS Interactive
Perpetually Adaptive Enterprise
Industries
expand here
Services
expand here
Products and Platforms
expand here
Research & Innovation
expand here
About Us
We deliver excellence and create value for customers and communities - everyday. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
TCS Insights
Point of views, research, studies - on the latest themes - to help you expand your knowledge and be future ready.
Want to be a global change-maker? Join our team.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Want to be a global change-maker? Join our team.
India
expand here
Americas
expand here
Asia Pacific
expand here
Europe and UK
expand here
Middle East and Africa
expand here
Management Commentary
expand here
Financials
expand here
News and Events
expand here
ESG
expand here
Resources
expand here
Top Results
Showing
10
01 - 07
Next-gen clinical trials via digital platform
Matthew Moyer, Director - Operations and supply tech, Merck, and Narayanan R., Chief Architect - TCS ADD™, discuss and demonstrate approaches and real-life examples to enable patient-centric trials through a unified, integrated platform.
14 MINS WATCH
You have these already downloaded
We have sent you a copy of the report to your email again.
Products and Platforms
TCS ADD™
This will open an overlay
TCS ADD™: A Suite of Modern and Open Technology Platforms
TCS ADD™ is a suite of modern and open technology platforms for clinical research and drug development that helps make clinical trials more agile and safe.
Related Insights
Join the TCS ADD™ forum at Pace Port™ London to explore AI/generative AI in clinical R&D and pharmacovigilance and how it is transforming life sciences.
Events
22 Sep 2025
Connect with our PV experts to know how our purpose-built AI-driven PV platform helps life sciences organizations drive efficiency and enhance patient safety.
Events
04 Nov 2025
Explore how leveraging AI and generative AI in medical research can streamline literature reviews, access databases, and improve clinical decision-making.
Article
26 Nov 2025
Highlights
- Merck partnered with TCS to realize its vision of a digitally enabled trials platform (DETP), leveraging TCS ADD’s decentralized trials solution.
- Merck and TCS jointly tested a host of features such as electronic date capture from device and reporting, auto reminders, interim data storage, API, passive data transfer, and bring-your-own-device (BYOD).
- The digitally enabled trials platform (DETP) aims to resolve challenges around protocol impact, supplier qualification and GxP procedures, managing data privacy, and calculating RoI.
Enabling patient-centric trials
Clinical trials have been primarily driven by a site-centric approach (such as face-to-face interactions at the site).
The COVID-19 pandemic severely impacted the functioning of traditional clinical trials and opened a world of possibilities to move to the next generation of clinical trials. Augmented by digital technologies, clinical trials improve participant access, engagement enabling patient-centricity.
Merck partnered with TCS to realize its vision of a digitally enabled trials platform (DETP), leveraging TCS ADD’s decentralized trials solution. The DETP was aimed at resolving challenges around protocol impact, supplier qualification and GxP procedures, managing data privacy, and calculating RoI.
The partnership facilitated a host of features being actively tested, viz-a-viz, electronic date capture from device and reporting, auto reminders, interim data storage, API, passive data transfer, and BYOD.
Related reading
1/4
TCS ADD™
Streamlining Medical Literature Analysis via AI and Generative AI
Article
|
26 Nov 2025
Opens in new tab
2/4
TCS ADD™
AI in Pharmacovigilance – Accelerating Innovation
White Paper
|
13 Nov 2025
Opens in new tab
3/4
AR/VR Revolutionizing Clinical Trial Monitoring and Data Analysis
Article
|
09 Sep 2025
Opens in new tab
4/4
AI-empowered Metadata Governance Wins Best Paper at PharmaSUG 2025
Article
|
03 Sep 2025
Opens in new tab
Transformation starts here
Integrated ecosystems are key to better patient outcomes.
Talk to our expertsFind out more
What’s on your mind?
We’re here to help! Tell us what you’re looking for and we’ll get you connected to the right people.
Looking for something else?